Andere talen Applied BioCode Corporation

Aandelen

6598

KYG0488D1051

slotkoers Taiwan S.E. Andere beurzen 00:00:00 30-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
19,75 ^TWD	-0,50%		-0,75%	-21,94%

15/04	Applied BioCode kondigt de lancering aan van het STI + Resistance Panel Assay, alleen voor onderzoeksdoeleinden	CI
21/03	Applied BioCode kondigt wijzigingen aan in CEO	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Applied BioCode Announces the Launch of the STI + Resistance Panel Assay for Research Use Only	15/04
Applied BioCode Announces the Launch of the STI + Resistance Panel Assay for Research Use Only	15/04
Applied BioCode Announces Retirement of CEO Chris Bernard	21/03
Applied BioCode Announces CEO Changes	21/03
Applied BioCode Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	14/03
Applied BioCode Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	13/11
Applied BioCode Appoints Industry Veteran Beth Laderman as Chief Scientific Officer	28-09-23
Applied BioCode Appoints Beth Laderman as Chief Scientific Officer	28-09-23
Applied BioCode Corporation Announces the Resignation of Michael Sean Aye as Research and Development Officer	23-09-23
Applied BioCode Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	28-08-23
Applied BioCode Corporation Announces the Change of Representative of Institutional Director	14-06-23
Applied BioCode Announces the Launch of the Fungal Panel Assay for Research Use	12-06-23
Applied Biocode Corporation Announces the Launch of the Fungal Panel Assay for Research Use	12-06-23
Applied BioCode Corporation Reports Earnings Results for the First Quarter Ended March 31, 2023	12-05-23
Applied BioCode Announces Distribution Agreement with Medline Industries	08-05-23
Applied BioCode Corporation Announces Distribution Agreement with Medline Industries	08-05-23
Applied BioCode Corporation Reports Earnings Results for the Full Year Ended December 31, 2022	22-03-23
Applied BioCode Corporation Reports Earnings Results for the Full Year Ended December 31, 2022	22-03-23
Applied BioCode Corporation Appoints Liang-Kai Huang as Corporate Governance Officer	13-03-23
Applied BioCode Announces 2022 Q4 and Full year Revenue	27-02-23

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Applied BioCode Corporation

Aandelen

6598

KYG0488D1051

Andere talen

Filters